A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations

被引：11
|
作者：
Chou, Wen-Chien [2 ]
Huang, Yen-Ning [2 ]
Huang, Chi-Fei
Tseng, Mei-Hsuan
Tien, Hwei-Fang [1 ]
机构：
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
来源：
BLOOD | 2010年 / 116卷 / 03期
关键词：
D O I：
10.1182/blood-2010-04-280636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 496
页数：2
相关论文
共 50 条
  • [21] Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders
    Chotirat, Sadudee
    Thongnoppakhun, Wanna
    Wanachiwanawin, Wanchai
    Auewarakul, Chirayu U.
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (03) : 286 - 291
  • [22] OVEREXPRESSION OF ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTANT PROTEIN RENDERS GLIOMA CELLS MORE SENSITIVE TO RADIATION
    Li, Sichen
    Chou, Arthur P.
    Chen, Weidong
    Chen, Ruihuan
    Deng, Yuzhong
    Phillips, Heidi S.
    Faull, Kym F.
    Cloughesy, Timothy
    Liau, Linda M.
    Lai, Albert
    NEURO-ONCOLOGY, 2012, 14 : 129 - 129
  • [23] An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
    Lewandowska, Marzena Anna
    Furtak, Jacek
    Szylberg, Tadeusz
    Roszkowski, Krzysztof
    Windorbska, Wieslawa
    Rytlewska, Joanna
    Jozwicki, Wojciech
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (01) : 45 - 53
  • [24] Increased Frequency of Presenting with Seizures in Patients with Isocitrate Dehydrogenase 1 (IDH1) Mutant Gliomas
    Chou, Arthur Po-Fei
    Ching, Harry
    Chang, Stephen
    Carrillo, Jose
    Lalezari, Shadi
    Spasic, Marko
    Choy, Winward
    Kim, Andrew
    Selfridge, Julia
    Quan, Jennifer
    Philippou, Yiannis
    Dye, Justin
    Soto, Horacio
    Nagasawa, Daniel
    Mathern, Gary
    Green, Richard
    Yang, Issac
    Prins, Robert
    Lai, Albert
    Liau, Linda
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A440 - A440
  • [25] An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors
    Verdura, Sara
    Cuyas, Elisabet
    Lozano-Sanchez, Jesus
    Bastidas-Velez, Cristian
    Llorach-Pares, Laura
    Fernandez-Arroyo, Salvador
    Hernandez-Aguilera, Anna
    Joven, Jorge
    Nonell-Canals, Alfons
    Bosch-Barrera, Joaquim
    Martin-Castillo, Begona
    Vellon, Luciano
    Sanchez-Martinez, Melchor
    Segura-Carretero, Antonio
    Menendez, Javier A.
    CARCINOGENESIS, 2019, 40 (01) : 27 - 40
  • [26] An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
    Marzena Anna Lewandowska
    Jacek Furtak
    Tadeusz Szylberg
    Krzysztof Roszkowski
    Wiesława Windorbska
    Joanna Rytlewska
    Wojciech Jóźwicki
    Molecular Diagnosis & Therapy, 2014, 18 : 45 - 53
  • [27] Immunohistochemical Demonstration of Isocitrate Dehydrogenase 1 (IDH1) Mutation in a Small Subset of Prostatic Carcinomas
    Mauzo, Shakuntala H.
    Lee, Michael
    Petros, John
    Hunter, Stephen
    Chang, Chi-Ming
    Shu, Hui-Kuo
    Bellail, Anita C.
    Hao, Chunhai
    Cohen, Cynthia
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (04) : 284 - 287
  • [28] A Comparison of Different Data Augmentation Methods in Isocitrate Dehydrogenase 1 (IDH1) Mutation Prediction
    Xiao, H.
    Chang, Z.
    MEDICAL PHYSICS, 2019, 46 (06) : E313 - E313
  • [29] Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
    Wang, Zheng
    Bao, Zhaoshi
    Yan, Wei
    You, Gan
    Wang, Yinyan
    Li, Xuejun
    Zhang, Wei
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [30] Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
    Zheng Wang
    Zhaoshi Bao
    Wei Yan
    Gan You
    Yinyan Wang
    Xuejun Li
    Wei Zhang
    Journal of Experimental & Clinical Cancer Research, 32
12345